Increasing
evidence supports a role for cytokines as chemical signals in the CNS, either under normal conditions or in the pathologic state. CNS levels of the cytokine interleukin-6 (IL-6) are known to be elevated in several diseases associated with developmental disorders and may contribute to the pathological state. To investigate the potential role of IL-6 in such disorders, neuronal effects of IL-6 were examined during development using an in vitro model system, cultured rat cerebellar granule neurons. The cultures were prepared from 6 d postnatal rat pups and exposed chronically to IL-6 (5 rig/ml) by addition to the culture medium. Neuronal effects of IL-6 were assessed by a comparison of calcium signals produced in control and IL-6 treated neurons by the glutamate receptor agonists NMDA and domoate and by K+ depolarization.
IL-6 treatment significantly enhanced the response to NMDA and altered the developmental pattern of NMDA sensitivity, whereas only minor changes were observed for the response to domoate and K+. Reducing extracellular calcium and depleting intracellular stores significantly decreased the amplitude of the response to NMDA in control and IL-6 treated neurons. However, the IL-6 treated neurons were significantly more sensitive to these treatments than control neurons. These results suggest that elevated levels of IL-6 can significantly alter CNS neuron development and response to excitatory transmitters, and that IL-6 pretreatment selectively enhances the intracellular calcium responses to NMDA by altering the relative contribution of extracellular calcium influx and release of calcium from stores to the calcium signal.
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Interleukin-6 is an important mediator of cellular communication both in physiological and pathological states (Hirano, 1992; Taga et al., 1992) . Elevated levels of cytokines, including IL-6, have been found in the cerebrospinal fluid (CSF) and brains of children and adults infected with the human immunodeficiency virus (HIV) (Laurenzi et al., 1990; Gallo et al., 1991; Perrella et al., 1992; Tyor et al., 1992) , and also in many other CNS diseases, such as Alzheimer's disease (Griffin et al., 1989) autoimmune disease (Hirohata and Miyamoto, 1990) , and meningitis caused by bacteria (Waage et al., 1989) and virus (Frei et al., 1989) . IL-6 receptors are known to be expressed in the CNS suggesting that they may play a role in CNS function (Schobitz et al., 1992; Sawada et al., 1993) . IL-6 receptors share a common intracellular subunit with neuronal growth factor receptors (Ip et al., 1992; Stahl et al., 1994) , and may influence neuronal development as well. However, little is known about the neuronal role of IL-6 and the consequences of its elevation in the diseased states. For example, elevated levels of IL-6 in the CNS of HIV infected children may abnormally activate IL-6 receptors and affect CNS development. These children are known to have congenital and developmental problems (Brenneman et al., 1990; Belman, 1994) . To assess IL-~'S potential for CNS effects in the developing nervous system, we have examined the acute and chronic effects of IL-6 exposure on an important neuronal function in the developing CNS, calcium signaling in response to stimulation of glutamate receptors. Calcium is an important intracellular messenger known to control many aspects of neuronal function including enzyme activity (e.g., kinases and phosphatases), gene expression, synapse function, and neurotransmitter release. Glutamate is the main excitatory transmitter in the CNS and is known to play an important role in neuronal development (McDonald et al., 1990b; Komuro and Rakic, 1993) . Therefore, IL-6 induced changes in calcium signaling could profoundly affect neuronal function in the developing nervous system. IL-~'S effects were examined in cultured cerebellar granule neurons grown in relative isolation from other cell types, such as microglia or astrocytes, which could also respond to the cytokine. Granule neurons express NMDA, AMPA, and kainate subtypes of glutamate receptors (Monaghan et al., 1989; Traynelis and Cull-Candy, 1991) . Calcium signaling elicited by activation of NMDA and kainate receptors was assessed using selective agonists, NMDA and domoate, respectively. Activation of these receptors increases intracellular calcium via several pathways: (1) calcium influx through receptor-gated channels, (2) calcium influx through voltage sensitive calcium channels activated by membrane depolarization, and (3) release of calcium from intracellular calcium stores. K+ depolarization was examined as well, which increases intracellular calcium via voltage-sensitive calcium channels and calcium release from intracellular calcium stores. IL-6 treatment substantially enhanced the calcium signals produced by NMDA stimulation but not by domoate stimulation or K+ depolarization. In addition, the developmental profile of NMDA responsivity was changed by IL-6 treatment. These results suggest that elevated levels of IL-6 could significantly influence NMDA receptor mediated processes and neuronal development in the CNS.
Materials and Methods
Cell culture. Cerebellar granule cells from 8 d old postnatal SpragueDawley rats were isolated by a standard enzyme treatment protocol based on the methods of Trenkner (1991) . Brieflv. cerebella were dissociated in calcium-free saline with'trypsin and l&ase, then plated on MATRIGEL (Collaborative Biomedical Products, Bedford, MA) coated coverglasses (-lo6 cell/ml). The neurons were grown in DMEMIF12 plus 10% horse serum supplemented with 30 mu glucose, 2 mu glutamine, 25 mu KCl, and 25 )LM penicillin-streptomycin; 0.5 ml of medium without serum was added every 7 d. Contaminating astrocytes were minimized by treatment with FUDR (20 pg/ml) on the first and fourth days after plating. The cultures survived for about 20 d in a standard CO, incubator.
IL-6, 5 rig/ml (500 U/ml), was added to the cell cultures 1 d after plating and supplemented again at day 4, 7, and 11. Control cultures consisted of sister cultures which were not treated with IL-6. The neurons were observed throughout the first 2 weeks in culture. The IL-6 containing medium was replaced by physiological saline before measurements were made. Zntrucellular calcium measurement. Intracellular calcium was determined for individual cells using standard microscopic fura-digital imaging (Grynkiewicz et al., 1985) and previously published methods (Hollidav and Gruol. 1993) . Granule neurons were loaded with 3 ILM fura-2/,4M for 30 min, then; for an additional 45 min, incubated in d)efree saline solution at room temperature to allow cleavage of acetoxymethyl (AM) ester. The coverglass was then mounted in a chamber attached to the stage of an inverted microscope equipped for furavideo images. Live video imagines of selected microscopic fields were recorded with SIT-66 video camera (DAGE-MTI) and digitized by computer. Ratio images were formed by a pixel-by-pixel division of the 340 nm excited image/the 380 nm excited image. Real time digitized display, image acquisition, and calcium measurements were made with MCID imaging software (Imaging Research Inc.). The somata of approximately 5-10 cells in each microscopic field were individually measured. Intracellular calcium levels were estimated by converting fluorescent ratios (340 nm/380 nm) to intracellular calcium concentration using the following formula: [Ca2+], = K,(R -R,,,)/R -R,,,)*FJF,, where R is the ratio value, R,,, is the ratio for a calcium free solution, R,,, is the ratio for a saturated calcium solution, K, is 135 (the dissociate constant for fura-2), F, is the intensity of a calcium free solution at 380 nm, and F, is the intensity of a saturated calcium solution at 380 nm. Calibration was done using fura salt (100 pM) in solutions of known calcium concentration. All experiments were performed at room temperature (23°C).
Drug application. Cells were stimulated with micropressure application of either NMDA (200 PM) or domoate (20 PM), selective agonists at the NMDA and kainate subtypes of glutamate receptors respectively, and K+ (150 mu; K+ substituted for Na+ in physiological saline) which causes membrane depolarization to -0 mV. The agonists were dissolved in bath saline and applied by a brief (1 set) micropressure pulse from drug pipettes (l-3 p,rn tip) placed under visual control near target neurons. K+ was applied in the same manner. A dye (fast green, 0.05 mg%) was included in the agonist solution to monitor neuronal exposure and showed that the agonist or K+ was rapidly distributed over an area sufficient to expose the target neurons. In control experiments, the dye had no effect by itself nor did it influence the response to NMDA.
Video images were collected at 3 set intervals for at least 12 set before stimulation and 100 set after stimulation. To ensure that the peak of the response was detected, the first collection after stimulation was made within 1 set of stimulation, with subsequent collections occurring at 3 set intervals. Control studies using shorter collection intervals confirmed that this collection paradigm was adequate to resolve response parameters. The time course of neuronal exposure to agonists was estimated by a series of control experiments on granule neurons using K+ (150 mu; K+ substituted for Na+ in physiological saline) depolarization. In electrophysiological studies, a 1 set application of the high K+ saline depolarized the membrane potential to 0 mV, as did bath application of the high K+ saline, indicating that a 1 set application period was sufficient to expose the neuronal surface to the full agonist concentration in the pipette. The maximum depolarization to K+ occurred 1.2 ? 0.07 seconds (n = 5) after stimulation and was maintained for 0.7 t 0.04 set (n = 5), indicating that the exposure period to the full agonist concentration was rather brief, but of sufficient duration to be detected by the first collection interval (1 set) if calcium changes paralleled membrane potential changes. The time for clearance of the agonist was estimated by the visual clearance of the dye (included in the agonist pipette) from the neuron, which took about 15 sec.
For NMDA stimulation, the cell bath and agonist solutions were magnesium-free physiological saline containing 5 FM glycine. For the stimulations of domoate and K+ depolarization, the bath contained normal physiological saline. In some experiments, the neurons were exposed to antagonists or other drugs by bath exchange. These drugs included MK-801, ethylene glyco-bis(P-aminoethyl ether)N,N,N',N'-tetraacetic acid (EGTA), dantrolene, caffeine, and 2,5-di(terr-butyl)l,4-benzohydroquinone (DTBHQ).
Drugs. Human recombinant interleukin-6 (IL-6) (Boehringer Mannheim, Germany) was dissolved in physiological saline at 100,000 U/ml as stock solution and stored at -20°C for no more than 3 weeks. NMDA and domoate were obtained from Tocris Neuramin, England, and stored as stock solutions at concentrations of 50 mu and 1 mM, respectively. MK-801 (Sigma Chemical CO. St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mu as a stock solution. The final concentration of DMSO was not more than 0.05% in the cell bath solution. In control experiments DMSO had no effects by itself. EGTA (Sigma Chemical Co., St. Louis, MO) was applied at a concentration of 1 mu to tritriate the extracellular calcium. Caffeine and dantrolene were purchased from Sigma Chemical Co. (St. Louis, MO). DTBHQ was purchased from Aldrich Chemical Co. (Milwaukee, WI).
Data analysis. Intracellular calcium responses were quantified by measurement of peak amplitude. Resting calcium levels were subtracted from all peak amplitude values on an individual cell basis. Each protocol consists of two or three culture sets of developing granule neurons, in which 5-15 granule neuronal somata in each field were measured. Data from several cultures were pooled for statistical analyses. Values are expressed as mean tSEM. Statistical significance was determined by one-way analysis of variance (ANOVA) followed by the Fisher posthoc test for multiple comparisons. p < 0.05 was considered indicative of a statistically significant difference.
Results
Granule neuron development in vitro Granule neurons obtained from 8 d old rat pup cerebellum and plated on glass coverslips coated with MATRIGEL show distinctive developmental changes during the culture period, thus providing an accessible developmental model. The morphological changes during development are shown in Figure 1 . At the time of plating, the granule neurons generally have a rounded shape. During the first day in culture, they attach to the substrate and start migrating. Gradually, clusters of cells form, and by the fifth day in culture, prominent fiber tracks are observed. The fiber tracks and clusters increase in size with culture age before 8 DIV, after which they appear relatively stable. Neurons in IL-6 treated cultures showed a similar developmental pattern.
NMDA induced intracellular calcium signals
The physiological properties of granule neurons including the sensitivity to NMDA, a selective agonist for the NMDA subtype of glutamate receptor, are known to change during development (Farrant et al., 1994; Hockberger et al., 1994; Monyer et al., 1994) . To determine if IL-6 could influence these properties, we examined the calcium response to stimulation with NMDA. IL-6 treatment significantly enhanced the calcium signals produced by NMDA stimulation in the cultured granule neurons. This effect was observed at all culture ages tested. Figure 2A -C shows typical intracellular calcium recordings from the cerebellar granule neurons in control cultures and in cultures chronically exposure to IL-6 (500 U/ml) for 6, 8, and 12 d prior to testing. In both control and IL-6 treated neurons, the calcium response evoked by NMDA was characterized by a rapid initial peak and slower recovery phase. The amplitudes of the calcium signals were significantly larger in IL-6 treated neurons compared to controls at all culture ages. Moreover, the calcium responses to NMDA in control neurons reached a peak at 6 DIV and then declined with development, whereas in IL-6 treated neurons the signal remained elevated throughout neuronal development. Mean values for the population of neurons studied are shown in Figure 20 . In control experiments, denatured (heating to 100°C for 30 min) IL-6 did not influence the response to NMDA in the granule neurons (not shown).
The effect of MK-801, a NMDA receptor antagonist, was tested to determine if the intracellular calcium responses to NMDA in both control and IL-6 treated neurons were induced by NMDA receptor activation. After the neurons were incubated in saline containing the noncompetitive NMDA receptor antagonist MK-801 (10 PM) for 5 min, NMDA did not induce a measurable increase of the intracellular calcium in either control (Fig.  3A) or IL-6 treated neurons (Fig. 3B) . These results indicate that the intracellular calcium changes produced by NMDA stimulation were specifically induced by NMDA receptor activation in both control and IL-6 treated neurons.
In addition to its effects on the NMDA response, IL-6 also altered resting calcium levels. Resting calcium levels varied during development but were consistently higher in the IL-6 treated neurons. For example the resting calcium levels were 43 -I 2 and 49 +-2 in control (n = 168) and IL-6 treated neurons (n = 180) respectively (p < 0.05) at 8 DIV.
K+ induced intracellular calcium signals Activation of NMDA receptors causes a membrane depolarization that could activate voltage sensitive calcium channels resulting in a calcium signal. An enhancement of this signal by IL-6 treatment could contribute to the larger response to NMDA in the IL-6 treated neurons. To test this possibility, the effect of IL-6 treatment on calcium signals elicited by K+ depolarization was investigated. K+ depolarization activates voltage-sensitive calcium channels independent of NMDA receptor activation. IL-6 treatment had no effect on the K+ evoked calcium signal or the developmental changes in the amplitude of this signal. Representative recordings are shown in Figure 4A -C and mean values in Figure 40 . Domoate induced intracellular calcium signals Granule neurons express multiple subtypes of glutamate receptors. Therefore, it was of interest to determine if responses evoked by another glutamate receptor agonist was affected by the IL-6 treatment. We examined the intracellular calcium responses to domoate, a kainate receptor agonist, at different developmental ages. Domoate stimulation produced an increase in intracellular calcium characterized by an initial peak and slow recovery phase in both control and IL-6 treated cultures. Representative responses are shown in Figure 5A- to domoate. Mean values are shown in Figure 5D . In both control and IL-6 treated neurons, the intracellular calcium responses to domoate peaked at 6 DIV and then declined with further neuronal maturation (Fig. 5) , a developmental pattern similar to that for the intracellular calcium responses to NMDA in control neurons (Fig. 2) .
The acute effects of IL-6 treatment cultured cerebellar granule neurons To test if acute treatment with IL-6 could produce effects similar to chronic treatment, acute IL-6 was applied by micropressure or bath application of a standard dose of IL-6 (500 U/ml) to neurons in control cultures and cultures chronically treated with same concentration of IL-6 for 4 d. In addition, in control cultures acutely treated with IL-6 the response to NMDA stimulation was monitored during acute bath addition of IL-6. Results are shown in Figure 6 . There was no measurable intracellular calcium response to IL-6 stimulation when IL-6 was applied by micropressure pulse (Fig. 6A ) to control and IL-6 treated neurons. Acute IL-6 via bath application did not significantly affect the intracellular calcium responses of control granule neurons to NMDA (Fig. 6&C) . These results indicated that acute IL-6 does not induce the same effects as chronic IL-6 on cerebellar granule neurons.
Influence of lowing extracellular calcium on N&IDA-induced intracellular calcium responses Extracellular calcium influxing through NMDA gated calcium channels contributes to the intracellular calcium signal in response to NMDA stimulation in cerebellar granule neurons. To test if the enhanced intracellular calcium responses to NMDA in IL-6 treated neurons were due to an increase dependence on extracellular calcium influx, we examined the effect of lowing extracellular calcium on the response to NMDA at different developmental ages. Results are summarized in Figure 7 .
In 5 DIV neurons, lowering extracellular calcium from 2.2 to 0.22 mu reduced the response to NMDA in both control and IL-6 treated neurons. Similar effects were observed in the 8 and 12 DIV neurons. However at the older ages (8 and 12 DIV), lowering extracellular calcium from 2.2 mu to 0.22 mM had a much greater effect on the intracellular calcium response to NMDA in IL-6 treated neurons (Fig. 7B) , almost completely eliminating the difference between control and IL-6 treated neurons. These result indicate that extracellular calcium is an important component of the NMDA response and contributes to the enhanced response in IL-6 treated cultures at older ages (8 and 12 DIV). The NMDA-induced intracellular calcium responses were eliminated in both control and IL-6 treated neurons when extracellular calcium was reduced to nominally calcium free by EGTA titration (Fig. 7C') .
Involvement of intracellular calcium stores in NMDA-induced intracellular calcium responses
Calcium induced calcium release (CICR) from intracellular calcium stores located on the endoplasmic reticulum could also contribute to NMDA induced intracellular calcium response in the granule neurons. Such release could be trigged by extracellular calcium influx via either NMDA-gated channels or voltagesensitive calcium channels activated by membrane depolarization. The increase in intracellular calcium could activate the ryanodine receptor causing release of calcium from stores controlled by that receptor. Changes in intracellular calcium could also modulate release of calcium from stores controlled by the inositol trisphosphate receptor (IP,), if such release occurs under resting conditions. NMDA did not elicit a calcium signal in the absence of extracellular calcium indicating that NMDA does not significantly stimulate production of IP, and calcium release via the IP receptor in the granule neurons. To examine the role of intracellular stores in NMDA-induced intracellular calcium responses, both control and IL-6 treated rat granule neurons at 5, 8, and 12 DIV were tested under the following conditions: (1) in the presence of 20 mM caffeine, which depletes intracellular calcium stores (Tsien and Tsien, 1990; Miller, 1991) ; (2) in the presence of 10 pM dantrolene, an antagonist of the ryanodine receptor (Tsien and Tsien, 1990; Miller, 1991; Charles et al., 1993) ; and (3) in the presence of 10 pM DTBHQ, which depletes the intracellular calcium stores by inhibiting the calcium ATPase of the endoplasmic reticulum that is responsible for sequestering calcium into these stores (Kass et al., 1989; Tsien and Tsien, 1990; Holliday et al., 1991) . Figure 8 shows the effect of caffeine on NMDA-induced intracellular calcium responses of cerebellar granule neurons in control and IL-6 treated neurons at different culture ages; 20 IIIM caffeine reduced the response to NMDA in both control and IL-6 treated neurons but the effects were much larger for the IL-6 treated neurons than for controls (Fig. 8) . At 5 DIV caffeine treatment abolished the difference between control and IL-6 treated neurons. At older ages (8 and 12 DIV) the difference between control and IL-6 treated neurons was greatly reduced by caffeine but not abolished. These results suggested that the intracellular calcium stores contribute not only to the intracellular calcium responses to NMDA in both control and IL-6 treated neurons but also to the enhanced intracellular calcium response to NMDA in the neurons chronically treated with IL-6.
The effects of dantrolene on control and IL-6 treated neurons are shown in Figure 9A . Dantrolene reduced the calcium responses to NMDA stimulation in IL-6 treated but not control neurons at 5 DIV and in both IL-6 treated and control neurons at 8 and 12 DIV. Thus, IL-6 treated neurons expressed sensitivity to dantrolene earlier in development than control neurons. At 5 DIV dantrolene abolished the difference in magnitude of the NMDA response between control and IL-6 treated neurons, . n is the total number of cells studied. The response to K+ depolarization was not significantly altered by IL-6 treatment during development.
whereas at older ages the difference was greatly reduced but not abolished, results similar to that observed with caffeine. These results show that the neurons were more sensitive to dantrolene at older ages (8 and 12 DIV) than at 5 DIV and that the IL-6 treated neurons were more sensitive to dantrolene than control neurons at all ages. In addition, the results indicate that increased calcium release through dantrolene-sensitive intracellular calcium stores contributes to the enhanced calcium signals of IL-6 treated neurons. Figure 9B shows that the effects of DTBHQ on the enhancement of the calcium responses to NMDA stimulation induced by IL-6 pretreatment during neuron development. DTBHQ reduced the calcium response to NMDA stimulation in both control and IL-6 treated neurons during neuronal development (Fig.  9B ). In addition, the neurons were more sensitive to DTBHQ at 5 DIV than at 8 DIV and the IL-6 treated neurons were more sensitive to DTBHQ than the control neurons at 8 and 12 DIV. These results indicate that the DTBHQ-sensitive intracellular calcium stores contribute to the increased calcium signals of IL-6 treated neurons at 8 and 12 DIV, consistent with results from studies with caffeine and dantrolene treatment.
Caffeine and DTBHQ treatment also altered resting calcium levels. Resting calcium level was increased by caffeine and DTBHQ in both control and IL-6 treated neurons. For example, mean resting calcium levels at 8 DIV were increased from 43 k 2 nM to 52 ? 2 nM (n = 66) by caffeine treatment of control neurons and from 49 ? 2 nM to 75 k 4 nM (n = 81) by caffeine treatment of IL-6 treated neurons. Dantrolene treatment did not consistently change resting calcium levels.
Discussion
In this study an enhanced intracellular calcium response to NMDA stimulation during neuronal development was observed in cultured rat granule neurons chronically treated with IL-6. In addition, the developmental pattern of NMDA responsivity of the granule neurons was altered by IL-6 and resting calcium levels were increased. IL-6 treatment did not significantly enhance the intracellular calcium responses to domoate stimulation of kainate receptors or K+-induced membrane depolarization and did not change the developmental profile for these stimulants. These results suggest that early exposure of granule neurons to IL-6 can alter neuronal function and development by selectively increasing the calcium response to NMDA.
The effects of IL-6 on the developing granule neurons required chronic exposure. Acute IL-6 did not reproduce the change in resting intracellular calcium levels or alter the calcium response to NMDA observed with chronic IL-6 treatment. Thus, IL-6 appears to exert its effects through a slow regulatory process such as receptor expression rather than by fast effects such as the changes in enzyme activities.
Activation of NMDA receptors increases intracellular calcium via several pathways: (1) calcium influx through receptor-gated channels, (2) calcium influx through voltage-gated calcium channels activated by membrane depolarization, and (3) release of calcium from intracellular calcium stores. Therefore IL-6 treatment could increase the response to NMDA by altering one or more of these pathways. Domoate and K+ depolarization increase intracellular calcium primarily by influx through voltagesensitive calcium channels due to membrane depolarization and release of calcium from intracellular stores, two of the same mechanisms involved in the calcium response to NMDA. The lack of effect of IL-6 on the response to domoate and K+ depolarization would appear to eliminate these common mecha- nisms as sites of IL-6 action. However, further studies with selective calcium channel antagonists and other pharmacological agents will be required before definitive statements can be made. Lowering extracellular calcium reduced the response to NMDA to a larger extent in IL-6 treated neurons than in control neurons, especially at the older culture ages studied (8 and 12 DIV). The greater dependence on extracellular calcium in the IL-6 treated neurons could reflect greater calcium influx and/or an enhanced coupling between influx and release such that larger release occurs in the IL-6 treated neurons, although the influx signal is the same as in control. Studies with caffeine, dantrolene and DTBHQ indicate that release from stores is greater in the IL-6 treated neurons compared to control neurons. Because IL-6 did not alter the responses to domoate and K+ depolarization, it is unlikely that IL-~'S effects on the NMDA response are primarily due to an IL-6 induced change in calcium influx via voltage-sensitive calcium channels. Increased calcium influx through NMDA-gated channels may be involved, due to an increase in the numbers of NMDA receptors or an increase in the permeability of the receptors to calcium. The subunit composition of the NMDA receptors in granule neurons is known to change during development (Pujic et al., 1993) and could be influenced by IL-6 treatment. Studies are in progress to address this issue.
Results from studies with various pharmacological agents that alter intracellular stores (e.g., caffeine) showed that release from intracellular stores also plays a prominent role in the enhanced response to NMDA in the IL-6 treated neurons. Others have shown that intracellular stores contribute to the calcium signal induced by NMDA in granule (Simpson et al., 1993) and other neuronal types (Segal and Manor, 1992) ; however, the effects on IL-6 on this response parameter has not been previously investigated. The enhanced release from stores could be triggered by enhanced calcium influx via NMDA receptor-gated channels in IL-6 treated neurons. Alternatively, the larger calcium response to NMDA in the IL-6 treated neurons could reflect a larger membrane depolarization, which would activate more voltage-sensitive calcium channels resulting in increased calcium influx via those channels and, consequently, greater release from intracellular calcium stores. The number or permeability of the voltage-sensitive calcium channels could be altered by IL-6 treatment as well. However, such an effect would be expected to alter the calcium response to domoate and K+ depolarization, which was not observed. Studies with selective calcium channel blockers are in progress to address these issues. Granule neurons are known to express at least four calcium channel types, L, N, P and Q (Forti et al., 1994) . The effects of IL-6 on the response to NMDA could also reflect a unique spatial relationship between the NMDA receptors and release channels for intracellular stores. Calcium channels and release channels for intracellular stores may not exhibit a similar relationship, thus explaining the lack of effect of IL-6 on K+ depolarization. Moreover, calcium release from overlapping, but nonidentical, intracellular calcium pools could contribute to the differences between NMDA stimt stimulation (applied at the arrow) in the presence of IL-6 (solid circle; IL-6 was also included in the micropipette), and in the absence of in granule neurons at 5 DIV. C displays mean values of resting calcium (Rest), peak calcium amplitude (Peak), calcium amplitude 30 set after stimulation (Ca30), and 60 set after stimulation (Ca60). The resting levels were subtracted from amplitude measurements. n is the number of cells studied. Acute treatment of IL-6 did not alter intracellular calcium level or the response to NMDA. to 0.22 mM (soEid circle) in both control and IL-6 treated granule neurons, respectively. The NMDA-induced intracellular calcium responses were eliminated in both control (open circle) and IL-6 treated neurons (solid circle) when EGTA titration was used to reduced the extracellular calcium to a nominally calcium-free level (c). D displays mean values of peak calcium amplitude at different extracellular calcium concentration in both control and IL-6 treated neurons during development Numbers in the histogram represent the number of cells studied. The responses to NMDA was more dependent on extracellular calcium in IL-6 treated neurons as compared to controls at the culture ages. ulation and K+ depolarization (Simpson et al., 1993) . Further studies will be necessary for a more complete understanding of the mechanisms underlying IL-6 actions on the calcium signals to NMDA.
During neuronal development the NMDA receptor responses in CNS have been reported to initially increase with age and then decline to adult levels in hippocampal neurons (McDonald et al., 1990a) , the visual system (Iwakiri and Komatsu, 1993) and granule neurons of the cerebellum (Farrant et al., 1994) . In our studies the ability of NMDA to induce an intracellular calcium response in cultured rat cerebellar granule neurons gradually increased to a peak at postnatal 6 DIV and then declined in magnitude, consistent with the developmental pattern observed for NMDA responses recorded electrophysiologically in granule neurons in slices obtained from postnatal animals (Farrant et al., 1994) . This developmental pattern was also observed for intracellular calcium responses to stimulations of control granule neurons with domoate, but not for K+-induced membrane depolarization.
After 6 DIV, the response to K+ depolarization remained constant at an elevated level, suggesting that the net calcium signal resulting from influx through the voltagesensitive calcium channels and release from stores remains relatively constant during neuronal development. Therefore, the decline in the NMDA and domoate induced calcium signals in control neurons during neuronal development may signify a developmental reduction in the number or the permeability to calcium of the NMDA and kainate receptors. In IL-6 treated neurons, the calcium responses to NMDA did not show this decline and remained elevated during development. These results suggest that early exposure of rat granule neurons to cytokines may alter the developmental expression of NMDA receptors or associated calcium signaling components in the granule neurons.
The rat granule neurons complements the previous study reported by Holliday et al. (1995) . In their study, chronic IL-6 treatment of cultured rat granule neurons enhanced the calcium response to glutamate stimulation at older culture ages (7 and 8 DIV), as was observed for NMDA stimulation in the current study, but depressed the response to glutamate at younger culture ages (4 and 5 DIV), a time when an enhanced response to NMDA was observed in our current study. In addition, in the studies of Holliday et al. (1995) , the response to K+ depolarization was enhanced by chronic IL-6 treatment, whereas in the current study no effect was observed. Several factors could account for these differences: (1) In the current study the intracellular calcium responses to activation of NMDA receptors was examined, whereas in the studies of Holliday et al. (1995) stimulation with glutamate was used, which would activate multiple subtypes of glutamate receptors, NMDA, AMPA, kainate and metabotropic receptors; (2) In the current study 8 d postnatal rats were used as a source of granule neurons, whereas 6-7 d postnatal rats were used in the studies of Holliday et al. (1995) ; (3) The granule neuron cultures used by Holliday et al. (1995) contained almost exclusively granule neurons, which were separated from other cell types by gravity centrifugation. Granule neurons are known to express messenger RNA for IL-6 receptors (Schobitz et al., 1993) , and thus the effects of IL-6 in these cultures are likely to result from direct actions of IL-6 on the granule neu-rons. The granule neuron cultures used in the current study were not subjected to this isolation procedure and thus other cell types, such as astrocytes and microglia, were present in relatively small numbers (FUDR treatment was used to restrict their numbers). These cell types can respond to and secrete cytokines or other factors which could then exert additional effects on the granule neurons. These differences raise interesting questions with respect to the influence of maturation and other cell types on the sensitivity and response of granule neurons to IL-6 treatment. Further studies will pursue these issues. NMDA receptors are known to play an important role in development (McDonald et al., 1990a,b) , synaptic plasticity (Kleinschmidt et al., 1987; McCabe and Horn, 1988) , and the generation of long-term potentiation (Bliss and Collingridge, 1993) and also in the pathological processes accompanying some neurological diseases in which the excessive calcium influx via NMDA-gated calcium channels and voltage-sensitive calcium channels might contribute to the subsequent neuronal injury (Greenamyre and Young, 1989; Choi, 1992; Lipton, 1992) . In addition, NMDA receptors have been proposed to be involved in neurotoxicity caused by viral proteins produced in HIV infection, in which the neurotoxicity could be prevented by cotreatment with an antagonist to NMDA (Lipton et al., 1991) or calcium channel blocker (Dreyer et al., 1990; Lipton, 1992) . The current demonstration of the enhancement of intracellular calcium signaling in response to NMDA stimulation in IL-6 treated neurons thus could have important functional implications under conditions of elevated IL-6 levels. Studies in transgenie mice indicate that overexpression of IL-6 can result in significant cerebellar damage (Campbell et al., 1993) . Although IL-6 toxicity was not observed in the current study, the functional alterations at cellular level during neuronal development could lead to calcium toxicity or excitotoxicity, which could be a contributing factor in the neuronal damage observed in vivo.
Cytokines are known to influence neuronal development, either by directly acting through their own receptors or by activating neuronal growth factor receptors . Thus, alterations in the normal cytokine levels in the brain are likely to affect CNS neuronal development and function. The mechanisms through which elevated cytokines affect neurons and their development are only beginning to be understood. Our studies of cultured granule neurons examining the relationship between NMDA receptor, cytokines and neuronal development demonstrate the potential for cytokines to alter this important aspect of neuronal function in the developing nervous system, either as a component of the neuronal developmental process or as a contributing factor in the pathologic state.
